Literature DB >> 33417978

Testing active membranes for bone regeneration: A review.

Manuel Toledano-Osorio1, Francisco Javier Manzano-Moreno2, Concepción Ruiz3, Manuel Toledano4, Raquel Osorio5.   

Abstract

OBJECTIVES: Maxillofacial bone defects are the main hindering conditions for traditional dental implant strategies. Guided Bone Regeneration (GBR) is used to handle this situation. The principle of GBR is to use a membrane to prevent the colonization of soft tissue cells of the bone defect and favors the migration of osteogenic linages. Current membranes do not completely fulfill the requirements that an optimal membrane should have, sometimes resulting in non-predictable results. Thus, the need to develop an ideal membrane to perform this duty is clear. Recent developments in bio-manufacturing are driving innovations in membranes technology permitting the active participation of the membrane in the healing and regenerative process trough native tissue mimicking, drug-delivery and cells interaction, away from being a passive barrier. New membranes features need specific evaluation techniques, beyond the International Standard for membrane materials (last reviewed in 2004), being this the rationale for the present review. Nanotechnology application has completely shifted the way of analyzing structural characterization. New progresses on osteoimmmunomodulation have also switched the understanding of cells-membranes interaction. DATA AND SOURCES: To propose an updated protocol for GBR membranes evaluation, critical reading of the relevant published literature was carried out after a MEDLINE/PubMed database search.
CONCLUSIONS: The main findings are that a potential active membrane should be assessed in its nanostructure, physicochemical and nanomechanical properties, bioactivity and antibacterial, osteoblasts proliferation, differentiation and mineralization. Immunomodulation testing for macrophages recruitment and M2 phenotype promotion in osteoblasts co-culture has to be achieved to completely analyze membranes/tissue interactions.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone regeneration; Macrophages; Membrane; Osteoblasts; Osteoimmunomodulation

Year:  2021        PMID: 33417978     DOI: 10.1016/j.jdent.2021.103580

Source DB:  PubMed          Journal:  J Dent        ISSN: 0300-5712            Impact factor:   4.379


  5 in total

Review 1.  Customized Barrier Membrane (Titanium Alloy, Poly Ether-Ether Ketone and Unsintered Hydroxyapatite/Poly-l-Lactide) for Guided Bone Regeneration.

Authors:  Yilin Shi; Jin Liu; Mi Du; Shengben Zhang; Yue Liu; Hu Yang; Ruiwen Shi; Yuanyuan Guo; Feng Song; Yajun Zhao; Jing Lan
Journal:  Front Bioeng Biotechnol       Date:  2022-06-28

2.  Histomorphometric Analysis of Differential Regional Bone Regeneration Induced by Distinct Doped Membranes.

Authors:  Manuel Toledano; Cristina Vallecillo; Aida Gutierrez-Corrales; Daniel Torres-Lagares; Manuel Toledano-Osorio; María-Angeles Serrera-Figallo
Journal:  Polymers (Basel)       Date:  2022-05-19       Impact factor: 4.967

Review 3.  The Use of Biocompatible Membranes in Oral Surgery: The Past, Present & Future Directions. A Narrative Review.

Authors:  Ioannis Kormas; Alessandro Pedercini; Hatem Alassy; Larry F Wolff
Journal:  Membranes (Basel)       Date:  2022-08-29

Review 4.  Zn-Containing Membranes for Guided Bone Regeneration in Dentistry.

Authors:  Manuel Toledano; Marta Vallecillo-Rivas; María T Osorio; Esther Muñoz-Soto; Manuel Toledano-Osorio; Cristina Vallecillo; Raquel Toledano; Christopher D Lynch; María-Angeles Serrera-Figallo; Raquel Osorio
Journal:  Polymers (Basel)       Date:  2021-05-29       Impact factor: 4.329

5.  Doxycycline-Doped Polymeric Membranes Induced Growth, Differentiation and Expression of Antigenic Phenotype Markers of Osteoblasts.

Authors:  Manuel Toledano-Osorio; Francisco J Manzano-Moreno; Manuel Toledano; Antonio L Medina-Castillo; Victor J Costela-Ruiz; Concepción Ruiz; Raquel Osorio
Journal:  Polymers (Basel)       Date:  2021-03-28       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.